Hear insights from experts: Dr Aline Chaves, Prof. Makoto Tahara and Dr Ranee Mehra explore the rationale and latest data for immunotherapy-based and targeted treatments in development for recurrent/metastatic SCCHN.
Watch now: touchoncologyi...
This activity is funded by an independent medical education grant from Seagen Inc. and Genmab US, Inc., and is jointly provided by USF Health and touchIME.
4 окт 2024
